BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26104754)

  • 1. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma.
    Lang BH; Wong CK
    Eur J Endocrinol; 2015 Sep; 173(3):367-75. PubMed ID: 26104754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
    Wong CK; Lang BH
    Ann Surg Oncol; 2014 Mar; 21(3):767-77. PubMed ID: 24276639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
    Lang BH; Wong CKH
    Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
    Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
    Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
    Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
    Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
    Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
    Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China.
    Lai M; Zhang MM; Qin QQ; An Y; Li YT; Yuan WZ
    Front Endocrinol (Lausanne); 2023; 14():1166433. PubMed ID: 37664842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effective management of low-risk papillary thyroid carcinoma.
    Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-minimization analysis comparing total thyroidectomy alone and total thyroidectomy with prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
    Lang BH; Wong CK
    Ann Surg Oncol; 2014 Feb; 21(2):416-25. PubMed ID: 23982258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the cost-effectiveness of laryngeal examination after elective total thyroidectomy.
    Lang BH; Wong CK; Tsang RK; Wong KP; Wong BY
    Ann Surg Oncol; 2014 Oct; 21(11):3548-56. PubMed ID: 24866435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.
    Baek HS; Ha J; Kim K; Bae J; Kim JS; Kim S; Lim DJ; Kim C
    J Korean Med Sci; 2023 Aug; 38(34):e264. PubMed ID: 37644680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis.
    Vidal-Trecan GM; Stahl JE; Eckman MH
    Thyroid; 2004 Nov; 14(11):933-45. PubMed ID: 15671772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
    Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
    Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
    Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.
    Zanocco K; Kaltman DJ; Wu JX; Fingeret A; Heller KS; Lee JA; Yeh MW; Sosa JA; Sturgeon C
    Ann Surg Oncol; 2018 Apr; 25(4):949-956. PubMed ID: 29417402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid Cancer: A Retrospective Study on a Korean Population.
    Baek HS; Ha J; Kim K; Bae JS; Kim JS; Kim S; Lim DJ; Kim CM
    Endocrinol Metab (Seoul); 2024 Apr; 39(2):310-323. PubMed ID: 38590123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis.
    Zanocco K; Elaraj D; Sturgeon C
    Surgery; 2013 Dec; 154(6):1148-55; discussion 1154-5. PubMed ID: 24383082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.